= 0.0584) in T2DM patients. DOPAC (1-100 μM) failed to stimulate insulin secretion in pancreatic β-cells. The multiplex assay showed variations in the cytokine levels between patients, but differences were not significant. This study demonstrates a potential use of RR in the treatment of inflammation and possibly IR as well in patients with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Uclés et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: